Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$23K Hold
36
﹤0.01% 409
2022
Q1
$26K Hold
36
﹤0.01% 428
2021
Q4
$25K Hold
36
﹤0.01% 431
2021
Q3
$25.1K Hold
36
﹤0.01% 725
2021
Q2
$22.4K Hold
36
﹤0.01% 786
2021
Q1
$23.1K Hold
36
﹤0.01% 729
2020
Q4
$23.1K Hold
36
﹤0.01% 681
2020
Q3
$22.5K Hold
36
﹤0.01% 623
2020
Q2
$22.9K Hold
36
﹤0.01% 600
2020
Q1
$23.4K Hold
36
﹤0.01% 527
2019
Q4
$27.1K Hold
36
﹤0.01% 587
2019
Q3
$28.1K Hold
36
﹤0.01% 563
2019
Q2
$30.7K Hold
36
﹤0.01% 568
2019
Q1
$31.6K Hold
36
﹤0.01% 566
2018
Q4
$26.7K Hold
36
﹤0.01% 573
2018
Q3
$25K Hold
36
﹤0.01% 639
2018
Q2
$21.6K Hold
36
﹤0.01% 659
2018
Q1
$22.7K Hold
36
﹤0.01% 649
2017
Q4
$22.7K Hold
36
﹤0.01% 648
2017
Q3
$24.2K Buy
+36
New +$23.1K ﹤0.01% 644

Other funds holding ATRI

RBC Europe's ATRI Position: Q2 2022 in Review

RBC Europe held its Atrion Corp (ATRI) position steady in Q2 2022 at 36 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #409.

RBC Europe first reported a position in ATRI in Q3 2017 and has held it in 20 quarters since. The position peaked at $31.6K in Q1 2019. 127 funds tracked by Wall St. Rank hold ATRI as of Q2 2022.

  • RBC Europe held 36 shares of Atrion Corp worth $23K as of Q2 2022.
  • RBC Europe left its Atrion Corp share count unchanged in Q2 2022.
  • Atrion Corp made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #409 holding.
  • RBC Europe first reported a position in Atrion Corp in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Atrion Corp position peaked at $31.6K in Q1 2019.
  • 127 funds tracked by Wall St. Rank held Atrion Corp as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.